Related Experiment Videos
Pathways of lymphatic drainage from the breast
S D Nathanson1, D L Wachna, D Gilman
1Department of Surgery, Henry Ford Health System, Detroit, Michigan 48202, USA. dnathan1@hfhs.org
Annals of Surgical Oncology
|January 5, 2002
Summary
Intradermal injection of radiocolloid and intraparenchymal injection of blue dye accurately map sentinel lymph nodes (SLNs) in breast cancer patients. Both injection routes effectively identify the same SLN, simplifying SLN mapping procedures.
Area of Science:
- Oncology
- Surgical Oncology
- Nuclear Medicine
Background:
- Sentinel lymph node (SLN) mapping is crucial for breast cancer staging.
- Current standard involves intraparenchymal injection of lymphophilic dye/radiocolloid near the tumor.
- Hypothesis: Common lymphatic trunks drain both breast parenchyma and skin, suggesting shared lymphatic pathways.
Purpose of the Study:
- To evaluate the efficacy of intradermal injection of radiocolloid compared to intraparenchymal injection of blue dye for SLN mapping.
- To determine if different injection routes lead to the same axillary lymph node.
Main Methods:
- 119 patients underwent intradermal injection of 99mTc-labeled filtered sulfur colloid over the breast tumor.
- Blue dye was injected intraparenchymally in the same (concordant) or different (discordant) quadrant as the primary tumor.
- Axillary exploration identified both blue (dye) and gamma-emitting (radiocolloid) nodes.
Main Results:
- The same SLN was identified as both hot (radiocolloid) and blue (dye) in 93.9% of concordant quadrant cases and 92.5% of discordant quadrant cases.
- No statistically significant difference (P = .99) was observed between concordant and discordant quadrant injections.
- In cases with distinct nodes, they were located very close to each other.
Conclusions:
- Dermal and parenchymal lymphatics of the breast appear to drain into the same axillary lymph nodes.
- Breast lymph drainage likely converges through a limited number of lymphatic trunks to one or two SLNs.
- Intradermal injection offers a potentially simpler and effective alternative for SLN mapping in breast cancer.